Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of MeiraGTx's Cevaretigene Ritoparvovec?
Cevaretigene Ritoparvovec is a gene therapy commercialized by MeiraGTx, with a leading Phase II program in Leber Congenital Amaurosis (LCA)....
Data Insights
Risk adjusted net present value: What is the current valuation of MeiraGTx's Cevaretigene Ritoparvovec?
Cevaretigene Ritoparvovec is a gene therapy commercialized by MeiraGTx, with a leading Phase II program in Leber Congenital Amaurosis (LCA)....